Most radiotherapy dose-prediction models use only CT images and anatomical structures, although intensity-modulated proton therapy (IMPT) dose also depends strongly on beam geometry and available clinical datasets are often small. We present DoseBridge, a denoising diffusion bridge model that uses the patient CT as a structured bridge endpoint and encodes plan-specific beam geometry in a spatially aligned beam mask. Multiscale fusion combines CT, target, organ-at-risk, and beam-mask representations with 1.95% additional parameters. DoseBridge was retrospectively evaluated on single-institution CT images and treatment plans from 52 patients with advanced-stage lung cancer treated with 60 Gy in 30 fractions; 42 cases were used for training and 10 for testing. Performance was assessed using image-similarity, dose-volume, and Lyman-Kutcher-Burman normal-tissue complication probability (NTCP) metrics and compared with two deep-learning models. On the test cohort, DoseBridge achieved a mean absolute error of 4.170 Gy, peak signal-to-noise ratio of 23.06 dB, and structural similarity index of 0.798, outperforming both comparison models on these metrics. Clinical target volume D95 differed from the reference dose by 0.62 +/- 1.6 Gy; signed organ-at-risk mean-dose differences ranged from -0.32 to 0.24 Gy, and NTCP differences were -0.40 +/- 2.2 and 0.52 +/- 3.4 percentage points for acute esophagitis and radiation pneumonitis, respectively. Changing only the beam mask redirected predicted low-dose entrance regions while preserving the high-dose target region. To our knowledge, DoseBridge is the first denoising diffusion bridge model for radiotherapy dose prediction. These results support its feasibility as a beam-aware planning prior for lung IMPT, pending evaluation in larger external cohorts.
San Lee, Nalee Kim, Jeong Il Yu +2eess.IV cs.AI cs.CV
In proton therapy planning, respiratory-gated non-contrast CT (NCCT) is commonly used for lesion segmentation; however, accurate delineation remains challenging due to low lesion-to-background contrast. Although learning-based methods have shown strong performance, they often struggle with non-contrast image segmentation. Inspired by clinical practice, where contrast-enhanced MRI is referenced to delineate lesions on NCCT, we propose ViPSAM, a visual prompting framework that leverages complementary cross-modality information. Built upon the Segment Anything Model (SAM), ViPSAM introduces a visual prompt encoder to extract guidance features from contrast-enhanced images and a visual-guided cross-attention module to integrate non-contrast and contrast-enhanced features, thereby enhancing lesion-relevant representations in low-contrast regions. The mask decoder is further adapted in a parameter-efficient manner to utilize visual prompts effectively. We evaluate the proposed method on liver lesion segmentation using NCCT acquired for proton therapy. Experimental results demonstrate that ViPSAM outperforms representative U-Net- and SAM-based methods, indicating that cross-modality visual prompting enables more robust and accurate segmentation in non-contrast images.